Molecular Partners to Participate in the TD Cowen 7th Annual Fall Oncology Innovation Summit - Molecular Partners (NASDAQ:MOLN)
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Molecular Partners AG ((SIX: MOLN, NASDAQ:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs
United States Laura Jeanbart Seth Lewis Patrick Amstutz Philippe Legenne Head Of Portfolio Management Communications
Source: benzinga.com